Trial intelligence / Profile preview

TAK-442 in Total Knee Replacement

NCT00641732Phase 2Completed

Sponsor
Takeda
Start
Oct 2007
Primary completion
Oct 2008
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 2 trial of letaxaban in venous thromboembolism (VTE), sponsored by Takeda. Started Oct 2007; status: completed.

02

Drugs

letaxaban
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on NCT00641732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00641732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call